Trial of SAVVY Vaginal Gel and HIV in Nigeria

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Biosyn
• Collaborators: FHI 360; United States Agency for International Development (USAID)

Criteria

Inclusion Criteria:

• 18 to 35 year old women

• HIV negative

• More than one sexual partner in past 3 months

• Average 3 coital acts per week

• Willing to use vaginal gel and condoms for 12 months

Exclusion Criteria:

• HIV positive

• Pregnant